ReviewWorld journal of gastroenterology2011
Management of Crohn's disease in smokers: is an alternative approach necessary?
Review in World journal of gastroenterology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 40 citations in OpenAlex.
- The Sasaki-W anastomosis for recurrent Crohn's disease stenosis after the Kono-S anastomosis.Surgical case reports · 2023Article
- Late onset crohns ileitis-A diagnostic dilemma.Journal of family medicine and primary care · 2022Article
- A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances.Biologics : targets & therapy · 2022Review
- Management of Crohn Disease: A Review.JAMA · 2021Review
- Prophylaxis of Crohn's disease recurrence: A surgeon's perspective.Annals of gastroenterological surgery · 2020Review
- The intestinal cholinergic anti-inflammatory pathway.The Journal of physiology · 2016Review
- Influence of environmental factors in the development of inflammatory bowel diseases.World journal of gastrointestinal pharmacology and therapeutics · 2016Review
- Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?World journal of gastrointestinal pathophysiology · 2014Review
- Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review.World journal of gastroenterology · 2014Review
- Optimizing post-operative Crohn's disease treatment.Annals of gastroenterology · 2014Review
- Bacterial microbiome of lungs in COPD.International journal of chronic obstructive pulmonary disease · 2014Review
- Review
- Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans.PloS one · 2013Article
- Impact of environmental and dietary factors on the course of inflammatory bowel disease.World journal of gastroenterology · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease is a chronic condition with a pathogenic background that involves both genetic and environmental factors. Although important progress has been made regarding the former in the last decade, scarce knowledge is available for the latter. In this sense, smoking remains the most important environmental factor in IBD. Active smoking increases the risk of developing Crohn's disease (CD). Moreover, CD patients who start or continue smoking after disease diagnosis are at risk for poorer outcomes such as higher therapeutic requirements and disease-related complications, as compared to those patients who quit smoking or who never smoked. However, the harmful effect of active smoking is not uniform in all patients or in all clinical scenarios. Interventions designed to facilitate smoking cessation may impact the course of the disease. In this article, the available evidence of the deleterious effects of smoking on CD is reviewed in detail, and alternative therapeutic approaches to CD in smokers are proposed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.